Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04740112 · ClinicalTrials.gov registry record · NA
Beta-glucan, Product Claims and Satiety
A NA study of Healthy, sponsored by General Mills.
- Completed
- Registry status
- NA
- Development phase
- 130
- Enrollment target
- 1
- Study location
NCT04740112: Completed NA study of Healthy, sponsored by General Mills.
NCT04740112 is a NA study of Healthy that has completed, run by General Mills. The registered enrollment target is 130 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04740112, a NA study of Healthy, has completed, sponsored by General Mills.
- COMPLETED
- Registry status
- NA
- Development phase
- 130 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a digital clinical trial to investigate satiety and consumer preference in responses to three test breakfast bars with varying level of dietary fiber, beta-glucan, and product packages (with or without product claims) in healthy adults.
Primary Outcome
Hunger as measured by visual analog scales in mm using appetite questionnaires
Conditions Studied
Interventions
- OTHER Foods with beta-glucan from oats and barley
Study Locations (1)
Minnesota
- No physical visit to a research facility is required. - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2021-01-28 |
| Est. Completion | 2021-06-30 |
| Phase | NA |
What the finished NCT04740112 record still lists
NCT04740112 is an interventional study that assigns participants to a tested intervention. The registered 130 participants enrollment target is mid-sized for trials with a published cap, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (80% lower).
The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which Foods with beta-glucan from oats and barley is the first listed.
NCT04740112 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT04740112 about?
NCT04740112 is a clinical study titled "Beta-glucan, Product Claims and Satiety". This is a digital clinical trial to investigate satiety and consumer preference in responses to three test breakfast bars with varying level of dietary fiber, beta-glucan, and product packages (with or without product claims) in healthy adults.
What is the current status of trial NCT04740112?
This trial is currently completed. It is a NA study. The enrollment target is 130 participants. The study started on 2021-01-28. Estimated completion is 2021-06-30.
What conditions does trial NCT04740112 study?
This clinical trial studies the following conditions: Healthy.
What interventions are being tested in trial NCT04740112?
The interventions under investigation include: Foods with beta-glucan from oats and barley (OTHER).
Who is sponsoring clinical trial NCT04740112?
This trial is sponsored by General Mills, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04740112 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04740112's enrollment target sits among peer trials
130 172nd of 1090 higher than 918 of 1,090 other Healthy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
-
Oxalate and Citrate in Humans - Response to Citrate
RECRUITING · NA
-
CArdioMEtabolic Function and Reserve Capacity in Healthy Adults: The CAMERA Study
RECRUITING · NA
-
Examining Bronchial Hyperresponsiveness in Primary Ciliary Dyskinesia
RECRUITING · NA
-
Medical Illustration Design Characteristic Evaluation
RECRUITING · NA
-
Sodium vs Potassium Education to Improve Vascular Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01492036 · 130 participants
Long-Term Follow-Up of Recipient of Gene Transfer Research
- NCT01631617 · 130 participants · Phase 2
Effects of Treatments on Atopic Dermatitis
- NCT02368041 · 130 participants
Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure
- NCT02604277 · 130 participants · NA
Suicidal Behavior in Patients Diagnosed With Bipolar Disorder
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI